NCT02769793View on ClinicalTrials.gov

Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

December 31, 2018

Conditions
Parkinson Disease
Interventions
DRUG

Levodopa dispersible

Levodopa dispersible 100mg/tablet, PO, 1 tablet in the morning, once daily for 4 weeks (crossover)

DRUG

Levodopa

Levodopa 100mg/tablet, PO, 1 tablet in the morning, once daily for 4 weeks (crossover)

Trial Locations (2)

Unknown

Samsung Medical Center, Seoul

SMG-SNU Boramae Medical Center, Seoul

All Listed Sponsors
collaborator

SMG-SNU Boramae Medical Center

OTHER

collaborator

Samsung Medical Center

OTHER

lead

Seoul National University Hospital

OTHER

NCT02769793 - Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON | Biotech Hunter | Biotech Hunter